Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
c.1 BC Cancer Agency KEL Library | Available |
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June 2015
Table of Contents:; I OVERVIEW -- II DIAGNOSTIC STUDIES -- III NERVOUS SYSTEM INVOLVEMENT OF SYSTEMIC CANCERS -- IV NEUROLOGICAL COMPLICATIONS OF CANCER -- V NEUROLOGICAL COMPLICATIONS OF CANCER THERAPY -- NEUROLOGICAL COMPLICATIONS OF SPECIFIC MALIGNANCIES -- VII NEUROLOGICAL COMPLICATIONS IN LONG…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 6-13 October 2015
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 24-31 May 2016
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 21-28 March 2017
Contents:; Chapter 1 Epidemiology of Cardio-Oncology -- Chapter 2 Cardiotoxicity of Anticancer Therapies -- Chapter 3 Screening and Monitoring for Cardiotoxicity during Cancer Treatment -- Chapter 4 Management of Chemotherapy-Associated Cardiomyopathy -- Chapter 5 Treatment of hypertension in patie…
Table of Contents:; Section 1 ONCOLOGY AND HEMATOLOGY PRINCIPLES FOR THE CARDIOLOGIST -- 1: PRINCIPLES OF CANCER TREATMENT -- 2: INTRODUCTION TO SYSTEMIC ANTINEOPLASTIC TREATMENTS FOR CARDIOLOGISTS --3: BASICS OF RADIATION THERAPY -- 4: CARDIAC TUMORS -- 5: CARDIAC TUMORS -- 6: CARDIAC TUMORS -- 7:…